United Therapeutics | UTHR - Assets


United Therapeutics reported $7.35B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Amarin USD 659.81M 10.31M Sep/2025
Ardelyx USD 486.17M 19.4M Sep/2025
Baxter International USD 20.06B 1.01B Dec/2025
Bayer EUR 104.21B 1.03B Sep/2025
BioCryst Pharmaceuticals USD 446.42M 10.76M Sep/2025
Biogen USD 29.44B 232M Dec/2025
BioMarin Pharmaceutical USD 7.61B 158.53M Sep/2025
Emergent BioSolutions USD 1.82B 69.9M Dec/2023
Esperion Therapeutics USD 364.02M 16.93M Sep/2025
Gilead Sciences USD 59.02B 490M Dec/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
Halozyme Therapeutics USD 2.53B 304.09M Dec/2025
Insmed USD 2.26B 96.18M Dec/2025
Ionis Pharmaceuticals USD 3.03B 47.96M Sep/2025
J&J USD 199.21B 6.39B Dec/2025
Lexicon Pharmaceuticals USD 225.58M 72.09M Jun/2025
Moderna USD 12.34B 203M Dec/2025
Omeros USD 200.57M 34.59M Jun/2025
Pfizer USD 208.73B 2.64B Sep/2025
PTC Therapeutics USD 2.9B 255.07M Dec/2025
Regeneron Pharmaceuticals USD 40.56B 389.3M Dec/2025
Sangamo BioSciences USD 97.56M 11.39M Jun/2025
Sarepta Therapeutics USD 3.49B 186.38M Sep/2025
Teva Pharmaceutical Industries USD 40.75B 892M Dec/2025
United Therapeutics USD 7.35B 556.9M Sep/2025
Vertex Pharmaceuticals USD 25.64B 780.7M Dec/2025